{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:16:41Z","timestamp":1648646201293},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/coc.0b013e3182a2d98d","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T21:33:59Z","timestamp":1374701639000},"page":"405-410","source":"Crossref","is-referenced-by-count":2,"title":["Phase I and Pharmacokinetic Study of Erlotinib Administered in Combination With Amrubicin in Patients With Previously Treated, Advanced Non\u2013small Cell Lung Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Sakiko","family":"Otani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiichiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Ryuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yokoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Mitsufuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuatsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kasajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Katono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Asakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":". Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(10)62101-0","article-title":". Non-small-cell lung cancer.","volume":"378","author":"Goldstraw","year":"2011","journal-title":"Lancet"},{"key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","article-title":". Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.","volume":"18","author":"Shepherd","year":"2000","journal-title":"J Clin Oncol"},{"key":"R4-15-20210128","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":". Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":". Erlotinib in previously treated non-small-cell lung cancer.","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-15-20210128","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/JTO.0b013e318168c815","article-title":". Second-line treatment of advanced non-small cell lung cancer.","volume":"3","author":"Gridelli","year":"2008","journal-title":"J Thorac Oncol"},{"key":"R7-15-20210128","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1021\/jo00229a010","article-title":". Stereospecific total synthesis of 9-aminoanthracyclines: ()-9-amino-9-deoxydaunomycin and related compounds.","volume":"52","author":"Ishizumi","year":"1987","journal-title":"J Org Chem"},{"key":"R8-15-20210128","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1349-7006.1998.tb00498.x","article-title":". Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.","volume":"89","author":"Yamaoka","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"R9-15-20210128","first-page":"189","article-title":"Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin.","volume":"2","author":"Yamamoto","year":"2009","journal-title":"Drug Des Devel Ther"},{"key":"R10-15-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10637-006-5937-2","article-title":". Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.","volume":"24","author":"Sawa","year":"2006","journal-title":"Invest New Drugs"},{"key":"R11-15-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10637-007-9039-6","article-title":". Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.","volume":"25","author":"Takeda","year":"2007","journal-title":"Investigational new drugs"},{"key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/JTO.0b013e3181c07c6c","article-title":". Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401).","volume":"5","author":"Kaneda","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R13-15-20210128","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2004.07.215","article-title":". Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.","volume":"22","author":"Herbst","year":"2004","journal-title":"J Clin Oncol"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1200\/JCO.2004.08.001","article-title":". Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.","volume":"22","author":"Giaccone","year":"2004","journal-title":"J Clin Oncol"},{"key":"R15-15-20210128","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1200\/JCO.2005.02.840","article-title":". TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"key":"R16-15-20210128","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.2005.05.1474","article-title":". Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.","volume":"25","author":"Gatzemeier","year":"2007","journal-title":"J Clin Oncol"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":". New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.ftd.0000185771.82620.ee","article-title":". Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients.","volume":"28","author":"Matsunaga","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchromb.2003.08.015","article-title":". Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor.","volume":"796","author":"Lepper","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R20-15-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2353\/jmoldx.2006.050104","article-title":". A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.","volume":"8","author":"Yatabe","year":"2006","journal-title":"J Mol Diagn"},{"key":"R21-15-20210128","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1200\/JCO.2001.19.13.3267","article-title":". Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.","volume":"19","author":"Hidalgo","year":"2001","journal-title":"J Clin Oncol"},{"key":"R22-15-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/annonc\/mdh188","article-title":". Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.","volume":"15","author":"Giaccone","year":"2004","journal-title":"Ann Oncol"},{"key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2011.40.1315","article-title":". Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.","volume":"30","author":"Janne","year":"2012","journal-title":"J Clin Oncol"},{"key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers--a different disease.","volume":"7","author":"Sun","year":"2007","journal-title":"Nat Rev Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e3182a2d98d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:10:16Z","timestamp":1620951016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201508000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3182a2d98d","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}